Secreted frizzled related-protein 2 (Sfrp2) deficiency decreases adult skeletal stem cell function in mice
Autor: | Yankel Gabet, Brian Sworder, Nathan J. Burbach, Byron W H Mui, Luis F de Castro, Kenn Holmbeck, Agnes D. Berendsen, Sergei A. Kuznetsov, Natasha Cherman, Pamela Gehron Robey, Matthew D. Phillips, Kathryn Futrega |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Frizzled
endocrine system Histology Stromal cell QH301-705.5 Physiology Endocrinology Diabetes and Metabolism Regeneration (biology) Mesenchymal stem cell Wnt signaling pathway LRP6 Biology Article Cell biology Bone quality and biomechanics RUNX2 stomatognathic system QP1-981 Biology (General) Stem cell Bone |
Zdroj: | Bone Research Bone Research, Vol 9, Iss 1, Pp 1-12 (2021) |
ISSN: | 2095-6231 2095-4700 |
Popis: | In a previous transcriptomic study of human bone marrow stromal cells (BMSCs, also known as bone marrow-derived “mesenchymal stem cells”), SFRP2 was highly over-represented in a subset of multipotent BMSCs (skeletal stem cells, SSCs), which recreate a bone/marrow organ in an in vivo ectopic bone formation assay. SFRPs modulate WNT signaling, which is essential to maintain skeletal homeostasis, but the specific role of SFRP2 in BMSCs/SSCs is unclear. Here, we evaluated Sfrp2 deficiency on BMSC/SSC function in models of skeletal organogenesis and regeneration. The skeleton of Sfrp2-deficient (KO) mice is overtly normal; but their BMSCs/SSCs exhibit reduced colony-forming efficiency, reflecting low SSC self-renewal/abundancy. Sfrp2 KO BMSCs/SSCs formed less trabecular bone than those from WT littermates in the ectopic bone formation assay. Moreover, regeneration of a cortical drilled hole defect was dramatically impaired in Sfrp2 KO mice. Sfrp2-deficient BMSCs/SSCs exhibited poor in vitro osteogenic differentiation as measured by Runx2 and Osterix expression and calcium accumulation. Interestingly, activation of the Wnt co-receptor, Lrp6, and expression of Wnt target genes, Axin2, C-myc and Cyclin D1, were reduced in Sfrp2-deficient BMSCs/SSCs. Addition of recombinant Sfrp2 restored most of these activities, suggesting that Sfrp2 acts as a Wnt agonist. We demonstrate that Sfrp2 plays a role in self-renewal of SSCs and in the recruitment and differentiation of adult SSCs during bone healing. SFRP2 is also a useful marker of BMSC/SSC multipotency, and a factor to potentially improve the quality of ex vivo expanded BMSC/SSC products. |
Databáze: | OpenAIRE |
Externí odkaz: |